Prevalence, Cumulative Incidence, Monotherapy and Combination Therapy, and Treatment Duration of Frequently Prescribed Psychoactive Medications in the Netherlands: Retrospective Database Analysis for the Years 2000 to 2005

Clinical Therapeutics

Volumn 32, Issue 14, 2010, Pages 2457-2466

  Ravera, Silvia ^a   Visser, Sipke T ^a   De Gier, Johan J ^a   De Jong van den Berg, Lolkje T W ^a  

^a UNIVERSITY OF GRONINGEN   (Netherlands)

Author keywords

Drug utilization; Pharmacoepidemiology; Psychotropic drugs

Indexed keywords

ANTIDEPRESSANT AGENT; ANXIOLYTIC AGENT; HYPNOTIC SEDATIVE AGENT; PSYCHOTROPIC AGENT; SEROTONIN UPTAKE INHIBITOR;

AGE DISTRIBUTION; ARTICLE; DATA BASE; DRIVING ABILITY; DRUG UTILIZATION; HUMAN; INCIDENCE; KAPLAN MEIER METHOD; MONOTHERAPY; NETHERLANDS; PHARMACOEPIDEMIOLOGY; PRESCRIPTION; PREVALENCE; RETROSPECTIVE STUDY; TREATMENT DURATION;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; AUTOMOBILE DRIVING; DATABASES, FACTUAL; DRUG ADMINISTRATION SCHEDULE; DRUG PRESCRIPTIONS; DRUG THERAPY, COMBINATION; DRUG UTILIZATION REVIEW; FEMALE; HUMANS; MALE; MIDDLE AGED; NETHERLANDS; PSYCHOTROPIC DRUGS; TIME FACTORS; YOUNG ADULT;

EID: 79951844944     PISSN: 01492918     EISSN: 1879114X     Source Type: Journal    
DOI: 10.1016/j.clinthera.2010.12.002     Document Type: Article

References (37)

1. Alonso J., Angermeyer M.C., Bernert S., et al. Psychotropic drug utilization in Europe: Results from the European Study of Epidemiology of Mental Disorders [ESEMeD) project. Acta Psychiatr Scand Suppl 2004, 109(Suppl):55-64. ESEMeD/ MHEDEA 2000 Investigators, European Study of the Epidemiology of Mental Disorders Project.
2. Koenig W., Rüther E., Filipiak B. Psychotropic drug utilization patterns in a metropolitan population. Eur J Clin Pharmacol 1987, 32:43-51.
3. Riska E., Klaukka T. Use of psychotropic drugs in Finland. Soc Sci Med 1984, 19:983-989.
4. Cooperstock R., Parnell P. Research on psychotropic drug use. A review of findings and methods. Soc Sci Med 1982, 16:1179-1196.
5. Movig K.L., Mathijssen M.P., Nagel P.H., et al. Psychoactive substance use and the risk of motor vehicle accidents. Accid Anal Prev 2004, 36:631-636.
6. Walsh J.M., de Gier J.J., Christopherson A.S., Verstraete A.G. Drugs and driving. Traffic Inj Prevent 2004, 5:241-253.
7. Barbone F., McMahon A.D., Davey P.G., et al. Association of road-traffic accidents with benzodiazepine use. Lancet 1998, 352:1331-1336.
8. Drummer O.H. The role of drugs in road safety. Aust Prescr 2008, 31:33-35.
9. White paper. European transport policy for 2010: Time to decide European Commission, Accessed February 2010. http://ec.europa.eu/%20transport/strategies/doc/2001_white_paper/lb_texte_complet_en.pdf.
10. Orriols L., Salmi L.R., Philip P., et al. The impact of medicinal drugs on traffic safety: A systematic review of epidemiological studies. Pharmacoepidemiol Drug Saf 2009, 18:647-658.
11. Raes E., Van den Neste T., Verstraete A.G. EMCDDA insights: Drug use, impaired driving and traffic accidents European Monitoring Centre for Drugs and Drug Addiction, Accessed April 2010. http://www.emcdda.europa.eu/attachements.cfm/att_65871_EN_Insight8.pdf.
12. Driving under the influence of drugs, alcohol and medicines DRUID, Accessed February 2009. http://www.druid-project.eu.
13. Ravera S., Hummel S.A., Stolk P., et al. The use of driving impairing medicines: A European survey. Eur J Clin Pharmacol 2009, 65:1139-1147.
14. IADB.nl database Accessed February 2009. http://www.iadb.nl.
15. Kalverdijk L.J., Tobi H., van den Berg P.B., et al. Use of antipsychotic drugs among Dutch youths between 1997 and 2005. Psychiatr Serv 2008, 59:554-560.
16. Schirm E., Tobi H., de Vries T., et al. Lack of appropriate formulations of medicines for children in the community. Acta Paediatr 2003, 92:1486-1489.
17. WHOCC-ATC/DDD Index 2010 Accessed January 2009. http://www.whocc.no/atcddd.
18. Driving under the influence [in Dutch]. Pharmaceutisch Weekblad 2009, 144:18. Accessed September 2009. http://www.sfk.nl/publicaties/farmacie_in_cijfers/2009/2009-26.html.
19. Wagner A.K., Ross-Degnan D., Gurwitz J.H., et al. Effect of New York State regulatory action on benzodiazepine prescribing and hip fracture rates. Ann Intern Med 2007, 146:96-103.
20. Allery L.A., Owen P.A., Robling M.R. Why general practitioners and consultants change their clinical practice: A critical incident study. BMJ 1997, 314:870-874.
21. Katz L.Y., Kozyrskyj A.L., Prior H.J., et al. Effect of regulatory warnings on antidepressant prescription rates, use of health services and outcomes among children, adolescents and young adults [published correction appears in CMAJ. 2008;178:1466]. CMAJ 2008, 178:1005-1011.
22. Moynihan R. Who pays for the pizza?. Redefining the relationships between doctors and drug companies. 1: Entanglement. BMJ 2003, 326:1189-1192.
23. Wazana A. Physicians and the pharmaceutical industry: Is a gift ever just a gift?. JAMA 2000, 283:373-380.
24. Neutel C.I., Walop W. Drug utilization by men and women: Why the differences?. Drug Inform J 2005, 39:299-310.
25. van Hulten R., Leufkens H.G., Bakker A. Usage patterns of benzodiazepines in a Dutch community: A 10-year follow-up. Pharm World Sci 1998, 20:78-82.
26. Del Rio M.C., Alvarez F.J. Medication use by the driving population. Pharmacoepidemiol Drug Saf 1996, 5:255-261.
27. Vrublevska K., Rukmane J., Burmistrs R., et al. Dispensing of psychotropic drugs to adults in community pharmacies in Latvia. Pharm World Sci 2008, 30:934-939.
28. Verster J.C., Mets M.A., Leufkens T.R., Vermeeren A. Insomnia, hypnotic drugs and traffic safety. Drugs, Driving, and Traffic Safety 2009, 233-244. Birkäuser, Boston, Mass. J.C. Verster, S.R. Pandi-Perumal, J.G. Ramaekers, J.J. de Gier (Eds.).
29. Vermeeren A., Leufkens T.M., Verster J.C. Effects of anxiolytics on driving. Drugs, Driving, and Traffic Safety 2009, 289-305. Birkäuser, Boston, Mass. J.C. Verster, S.R. Pandi-Perumal, J.G. Ramaekers, J.J. de Gier (Eds.).
30. Neutel C.I. Risk of traffic accident injury after a prescription for a benzodiazepine. Ann Epidemiol 1995, 5:239-244.
31. Engeland A., Skurtveit S., Mørland J. Risk of road traffic accidents associated with the prescription of drugs: A registry-based cohort study. Ann Epidemiol 2007, 17:597-602.
32. Vollebergh W.A., de Graaf R., ten Have M., et al. Mental Impairments in the Netherlands: Overview of the Results of NEMESIS 2003, [in Dutch], Trimbos-Instituut, Utrecht, the Netherlands.
33. Bijl R.V., Ravelli A., van Zessen G. Prevalence of psychiatric disorder in the general population: Results of the Netherlands Mental Health Survey and Incidence Study. Soc Psychiatry Psychiatr Epidemiol 1998, 33:587-595.
34. Karow A., Lambert M. Polypharmacy in treatment with psychotropic drugs: The underestimated phenomenon. Curr Opin Psychiatry 2003, 16:713-718.
35. Ananth J., Parameswaren S., Gunatilake S. Antipsychotic polypharmacy. Curr Pharm Des 2004, 10:2231-2238.
36. Ashton H. Guidelines for rational use of benzodiazepines. When and what to use. Drugs 1994, 48:25-40.
37. National Institute for Health and Clinical Excellence, Accessed October 2010. http://www.nice.org.uk.